BMT_GVHD_DRUGS

Description:

The list of drugs to be used for graft vs. host disease (GVHD) prophylaxis.

Primary Key

Column Name	Ordinal Position
REGIMEN_ID	1
CONTACT_DATE_REAL	2
LINE	3

Column Information

	Name	Type	Discontinued?
1	REGIMEN_ID	NUMERIC	No
	The unique identifier for the blood and marrow transplant treatment regimen.
2	CONTACT_DATE_REAL	FLOAT	No
	A unique contact date in decimal format. The integer portion of the number indicates the date of contact. The digits after the decimal distinguish different contacts on the same date and are unique for each contact on that date. For example, .00 is the first/only contact, .01 is the second contact, etc.
3	LINE	INTEGER	No
	The line number for the information associated with this contact. Multiple pieces of information can be associated with this contact.
4	CONTACT_DT	DATETIME	No
	The date of this contact in calendar format.
5	GVHD_DRUG_C_NAME	VARCHAR	No
	The graft versus host disease drugs to use May contain organization-specific values: Yes Category Entries: Tacrolimus (FK 506) Cyclosporine (CSA, Neoral, Sandimmune) Mycophenolate mofetil (MMF) (CellCept) Sirolimus (Rapamycin, Rapamune) Methotrexate (MTX) (Amethopterin) ALG/ALS/ATG/ATS Extra-corporeal photopheresis (ECP) Etanercept Alemtuzumab In vivo immunotoxin Infliximab Cyclophosphamide (Cytoxan) Anti CD 25 (Zenapax, Daclizumab, AntiTAC) Other agent In vivo monoclonal antibody Blinded randomized trial Corticosteroids (systemic) Everolimus Abatacept Bortezomib CD34 enriched (CD34+ selection) Ex-vivo T-cell depletion Filgotinib Maraviroc Ruxolitinib Tocilizumab